Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Qualigen Therapeutics, Inc.

Qualigen Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Rule
From Qualigen Therapeutics, Inc.
Via GlobeNewswire
Tickers QLGN
Qualigen Therapeutics Announces Pre-IND Feedback from U.S. Food and Drug Administration Regarding QN-302 for the Treatment of G4-Targeted Advanced Solid Tumors
From Qualigen Therapeutics, Inc.
Via GlobeNewswire
Tickers QLGN
Qualigen Therapeutics, Inc. Announces 1-for-10 Reverse Stock Split
From Qualigen Therapeutics, Inc.
Via GlobeNewswire
Tickers QLGN
Qualigen Therapeutics, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
From Qualigen Therapeutics, Inc.
Via GlobeNewswire
Tickers QLGN
Qualigen Therapeutics Announces Two Posters of Its RAS-Targeted Inhibitor Program at the National Cancer Institute
From Qualigen Therapeutics, Inc.
Via GlobeNewswire
Tickers QLGN
Qualigen Therapeutics to Present at LD Micro Main Event XV
From Qualigen Therapeutics, Inc.
Via GlobeNewswire
Tickers QLGN
Qualigen Therapeutics to Present Two Posters at the National Cancer Institute Fourth RAS Initiative Symposium
From Qualigen Therapeutics, Inc.
Via GlobeNewswire
Tickers QLGN
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.